MEDICAL COMMUNITY

Chronic migraine in Italy: Chronic Migraine is officially regulated as a social disease in Italy

Chronic migraine in Italy has finally been recognized as the serious diseases it is. The Italian senate has approved the recognition of primary chronic headache as a social disease,  a huge step towards the acknowledgment of migraine as the serious illness it is. On April 18, 2019 the Chamber passed the bill and 15 months …

Chronic migraine in Italy: Chronic Migraine is officially regulated as a social disease in Italy Read More »

migraine and covid-19

Covid-19 & migraine and other headaches: Webinar by Vall d’Hebron

Watch the first webinar for patients on Covid-19 and its impact on migraine and other headaches streamed by Vall d’Hebron Hospital with the support of EMHA.

Learn about the impact of the virus on patients with migraine, the possible risks associated with the treatments and advice on reducing the negative  impact of the lock down during migraine and other headaches episodes.

Migraine in the workplace

European survey on migraine in the workplace. Analysis of results and conclusions. The objective of this study is to know the situation of migraine workers within the workplace and compare the situation in the different participating countries. Read de complete document in our Study section About the study of Migraine in the workplace The objective …

Migraine in the workplace Read More »

Suggestions for headache care at coronavirus time

Suggestions for headache care at coronavirus time by  The European Headache Federation (EHF) and The European Migraine & Headache Alliance (EMHA) Coronavirus pandemia has completely changed health systems’ organization and priorities. Headache service are heavily affected by those changes. They have been suspended or reduced, to limit social contacts. Patients also would rather stay at home. …

Suggestions for headache care at coronavirus time Read More »

European Migraine Day of Action with MEPS in the European Parliament

Each year, September 12th is the European Migraine Day of Action. Today, EMHA’s President and Executive Director have been invited by MEP Esteban Gonzalez Pons and MEP Dolors Montserrat to the European Parliament to discuss about how to better help the affected ones to give light to the disease and how to improve the life …

European Migraine Day of Action with MEPS in the European Parliament Read More »

New drugs, decades in the making, are providing relief for migraines.

Nancy Baum Lipsitz remembers the night the pain began. She’d had a glass of white wine with a friend and went to bed with a terrible headache. The next day, she still felt horrible, the beginning of what she called a “rolling tide” of near constant migraines and lower level headaches. For three years she …

New drugs, decades in the making, are providing relief for migraines. Read More »

“Green light” to Lilly’s monoclonal antibody to migraine

Eli Lilly announces that the European Commission (EC) has approved the commercialization of galcanezumab ( Emgality ) as a prophylactic treatment of migraine in adults suffering from at least four days of migraine per month . Galcanezumab is a humanized monoclonal antibody that binds to the peptide related to the calcite gene (CGRP, for its acronym in English) associated with episodes …

“Green light” to Lilly’s monoclonal antibody to migraine Read More »

Scroll to Top